Seres Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Seres Therapeutics, Inc. (MCRB) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 16.58 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2023-03-07
- Seres Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-03-31 was 11.89M shares, a 10.20% increase year-over-year.
- Seres Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-03-31 was 10.79M shares, a 19.02% increase year-over-year.
- Seres Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-09-30 was 8.42M shares, a 8.83% increase year-over-year.
- Seres Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-06-30 was 8.80M shares, a 13.21% increase year-over-year.
- Seres Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 16.58M shares, a 33.52% increase from fiscal 2021.
- Seres Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 12.42M shares, a 23.50% increase from fiscal 2020.
- Seres Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 10.05M shares, a 17.86% increase from fiscal 2019.
- Seres Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 8.53M shares, a 8.83% increase from fiscal 2018.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | 16.58M shares 10-K · filed 2023-03-07 | ||||||
| 2021-12-31 | 12.42M shares 10-K · filed 2023-03-07 | ||||||
| 2021-06-30 | 12.18M shares 10-Q · filed 2021-08-03 | ||||||
| 2021-03-31 | 11.89M shares 10-Q · filed 2021-05-04 | ||||||
| 2020-12-31 | 10.05M shares 10-K · filed 2023-03-07 | ||||||
| 2020-09-30 | 9.81M shares 10-Q · filed 2020-11-09 | ||||||
| 2020-06-30 | 11.62M shares 10-Q · filed 2021-08-03 | ||||||
| 2020-03-31 | 10.79M shares 10-Q · filed 2021-05-04 | ||||||
| 2019-12-31 | 8.53M shares 10-K · filed 2022-03-01 | ||||||
| 2019-09-30 | 8.42M shares 10-Q · filed 2019-11-05 | 8.42M shares 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | 8.80M shares 10-Q · filed 2019-08-06 | 8.80M shares 10-Q · filed 2020-07-28 | |||||
| 2019-03-31 | 9.07M shares 10-Q · filed 2020-05-07 | ||||||
| 2018-12-31 | 7.84M shares 10-K · filed 2021-03-02 | ||||||
| 2018-09-30 | 7.73M shares 10-Q · filed 2019-11-05 | 7.73M shares 10-Q · filed 2018-11-08 | 7.73M shares 10-Q · filed 2019-11-05 | 7.73M shares 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | 7.77M shares 10-Q · filed 2019-08-06 | 7.77M shares 10-Q · filed 2019-08-06 | |||||
| 2018-03-31 | 7.80M shares 10-Q · filed 2019-05-02 | ||||||
| 2017-12-31 | 6.48M shares 10-K · filed 2020-03-02 | ||||||
| 2017-09-30 | 6.54M shares 10-Q · filed 2018-11-08 | 6.54M shares 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | 6.72M shares 10-Q · filed 2018-08-02 | 6.72M shares 10-Q · filed 2018-08-02 | |||||
| 2017-03-31 | 6.66M shares 10-Q · filed 2018-05-09 | ||||||
| 2016-12-31 | 5.18M shares 10-K · filed 2019-03-06 | ||||||
| 2016-09-30 | 5.17M shares 10-Q · filed 2017-11-08 | 5.17M shares 10-Q · filed 2017-11-08 | |||||
| 2016-06-30 | 5.61M shares 10-Q · filed 2017-08-03 | 5.61M shares 10-Q · filed 2017-08-03 | |||||
| 2016-03-31 | 5.88M shares 10-Q · filed 2017-05-04 | ||||||
| 2015-12-31 | 5.03M shares 10-K · filed 2018-03-08 | ||||||
| 2015-09-30 | 4.84M shares 10-Q · filed 2016-11-10 | 4.84M shares 10-Q · filed 2016-11-10 | |||||
| 2015-06-30 | 4.90B shares 10-Q · filed 2015-08-10 | 4.90M shares 10-Q · filed 2016-08-11 | 4.90B shares 10-Q · filed 2015-08-10 | ||||
| 2015-03-31 | 27.71M shares 10-Q · filed 2016-05-16 | ||||||
| 2014-12-31 | 25.94M shares 10-K · filed 2017-03-16 | ||||||
| 2014-09-30 | 19.28M shares 10-Q · filed 2015-11-12 | 19.28M shares 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | 17.51B shares 10-Q · filed 2015-08-10 | 17.51B shares 10-Q · filed 2015-08-10 | |||||
| 2013-12-31 | 12.03M shares 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |